The Bone Marrow-Mediated Protection of Myeloproliferative Neoplastic Cells to Vorinostat and Ruxolitinib Relies on the Activation of Jnk and Pi3K Signalling Pathways
AuthID
P-00J-Y5W
P-00J-Y5W
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service